Biochemical and clinical effects of γ‐vinyl GABA in patients with epilepsy
Biochemical and clinical effects of γ‐vinyl GABA in patients with epilepsy
复制标题
γ-乙烯基 GABA 对癫痫患者的生化和临床效果
DOI:
10.1212/wnl.34.2.182
复制
发表时间:
1984
期刊:
影响因子:
9.9
通讯作者:
A. Sjoerdsma
中科院分区:
文献类型:
--
作者:
P. Schechter;N. Hanke;J. Grove;N. Huebert;A. Sjoerdsma
Article abstract-In a pilot single-blind study, γ-vinyl GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase (GABA-T), was administered orally to 10 epileptic patients who were refractory to conventional anticonvulsant therapy. Daily doses of 1 g and 2 g for 2 weeks each as add-on therapy were followed by 2 weeks of placebo treatment. CSF obtained from suboccipital and lumbar punctures demonstrated dose-related increases in concentrations of free and total GABA and homocarnosine with treatment, but no changes in 5-hydroxyindoleacetic acid or homovanillic acid levels, indicating effective and selective CNS GABA-T inhibition. These biochemical changes were associated with decreased seizure frequency in seven patients, decreased seizure severity in one, no change in one, and possible worsening in one. γ-Vinyl GABA may be useful in the therapy of epilepsy.